| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | 2.16.840.1.113762.1.4.1110.62 |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1110.62/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.62 |
| Version | 20210409 |
| Status | active |
| Date | 2021-04-09T01:00:21-04:00 |
| Name | AntithromboticTherapyForIschemicStroke |
| Title | Antithrombotic Therapy for Ischemic Stroke |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this value set is to represent concepts of medications that are anticoagulant and antiplatelet medications used to reduce stroke mortality and morbidity.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication that is an antithrombotic medication, including oral, rectal, and injectable dose forms.),(Exclusion Criteria: Excludes concepts that represent enoxaparin and heparin generally given for VTE prophylaxis.) |
FHIR